ISRG
Intuitive Surgical, Inc. NASDAQ Listed Jun 16, 2000$406.78
+1.14%
vs $402.18
Mkt Cap $147.5B
52w Low $402.18
2.4% of range
52w High $592.85
50d MA $439.73
200d MA $490.69
P/E (TTM)
51.7x
EV/EBITDA
39.1x
P/B
8.1x
Debt/Equity
0.0x
ROE
17.1%
P/FCF
59.2x
RSI (14)
40.70
ATR (14)
$11.36
Beta
1.68
50d MA
$439.73
200d MA
$490.69
Avg Volume
2.5M
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
1020 Kifer Road · Sunnyvale, CA 94086-5304 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | AMC | 2.12 | 2.50 | +17.9% | 451.29 | +2.2% | +7.2% | -1.0% | +0.7% | -2.3% | -0.9% | — |
| Jan 22, 2026 | AMC | 2.27 | 2.53 | +11.5% | 525.81 | +0.8% | -0.3% | +0.9% | -0.7% | -0.6% | -2.8% | — |
| Oct 21, 2025 | AMC | 1.99 | 2.40 | +20.6% | 462.74 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% | — |
| Jul 22, 2025 | AMC | 1.93 | 2.19 | +13.5% | 511.00 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% | — |
| Apr 22, 2025 | AMC | 1.74 | 1.81 | +4.0% | 478.74 | +4.4% | +1.9% | +4.1% | +1.3% | -0.1% | +0.2% | — |
| Jan 23, 2025 | AMC | 1.76 | 2.21 | +25.6% | 608.66 | -4.4% | -4.0% | -1.8% | +0.1% | -0.2% | +1.3% | — |
| Oct 17, 2024 | AMC | 1.63 | 1.84 | +12.9% | 473.73 | +4.7% | +10.0% | -0.4% | -0.3% | -1.0% | -0.2% | — |
| Jul 18, 2024 | AMC | 1.54 | 1.78 | +15.6% | 416.14 | +8.0% | +9.3% | +1.3% | -1.3% | -0.2% | -3.8% | — |
| Apr 18, 2024 | AMC | 1.41 | 1.50 | +6.4% | 372.63 | +3.4% | -1.7% | +0.7% | +2.2% | -0.5% | -0.5% | — |
| Jan 23, 2024 | AMC | 1.48 | 1.60 | +8.1% | 371.41 | +3.4% | -0.4% | +1.3% | -0.1% | +1.2% | -0.5% | — |
| Oct 19, 2023 | AMC | 1.41 | 1.46 | +3.5% | 273.45 | -4.9% | -2.4% | +2.1% | +1.8% | -3.9% | -2.7% | — |
| Jul 20, 2023 | AMC | 1.33 | 1.42 | +6.8% | 347.66 | -3.4% | -3.2% | -3.9% | +2.3% | -0.5% | -1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 | Barclays | Maintains | Overweight → Overweight | — | $483.62 | $484.50 | +0.2% | -1.0% | +0.7% | -2.3% | -0.9% | -2.7% |
| Apr 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $451.29 | $461.36 | +2.2% | +7.2% | -1.0% | +0.7% | -2.3% | -0.9% |
| Apr 22 | BTIG | Maintains | Buy → Buy | — | $451.29 | $461.36 | +2.2% | +7.2% | -1.0% | +0.7% | -2.3% | -0.9% |
| Apr 22 | Leerink Partners | Maintains | Outperform → Outperform | — | $451.29 | $461.36 | +2.2% | +7.2% | -1.0% | +0.7% | -2.3% | -0.9% |
| Apr 22 | Baird | Maintains | Outperform → Outperform | — | $451.29 | $461.36 | +2.2% | +7.2% | -1.0% | +0.7% | -2.3% | -0.9% |
| Apr 15 | Truist | Maintains | Buy → Buy | — | $467.22 | $469.55 | +0.5% | +0.2% | -2.2% | +2.4% | -0.8% | -3.1% |
| Apr 13 | Mizuho | Maintains | Neutral → Neutral | — | $450.62 | $448.17 | -0.5% | +1.9% | +1.8% | +0.2% | -2.2% | +2.4% |
| Apr 10 | BTIG | Maintains | Buy → Buy | — | $454.94 | $455.69 | +0.2% | -0.9% | +1.9% | +1.8% | +0.2% | -2.2% |
| Apr 9 | Goldman Sachs | Maintains | Buy → Buy | — | $462.28 | $459.32 | -0.6% | -1.6% | -0.9% | +1.9% | +1.8% | +0.2% |
| Apr 6 | Evercore ISI | Maintains | In Line → In Line | — | $452.07 | $451.06 | -0.2% | +0.1% | +0.1% | +2.1% | -1.6% | -0.9% |
| Mar 17 | UBS | Maintains | Neutral → Neutral | — | $483.46 | $487.54 | +0.8% | -0.1% | -1.0% | +0.5% | -0.4% | +0.0% |
| Mar 11 | Citigroup | Upgrade | Neutral → Buy | — | $485.85 | $489.23 | +0.7% | +1.4% | -2.8% | -1.5% | +2.4% | -0.1% |
| Feb 24 | UBS | Maintains | Neutral → Neutral | — | $492.10 | $489.69 | -0.5% | +0.4% | +2.5% | +0.1% | -0.7% | -1.4% |
| Jan 27 | Freedom Capital Markets | Upgrade | Hold → Buy | — | $528.81 | $532.61 | +0.7% | -0.7% | -0.6% | -2.8% | -0.7% | -1.5% |
| Jan 26 | Barclays | Maintains | Overweight → Overweight | — | $523.99 | $523.95 | -0.0% | +0.9% | -0.7% | -0.6% | -2.8% | -0.7% |
| Jan 26 | Freedom Broker | Upgrade | Hold → Buy | — | $523.99 | $523.95 | -0.0% | +0.9% | -0.7% | -0.6% | -2.8% | -0.7% |
| Jan 23 | Evercore ISI | Maintains | In Line → In Line | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.9% | -0.7% | -0.6% | -2.8% |
| Jan 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.9% | -0.7% | -0.6% | -2.8% |
| Jan 23 | BTIG | Maintains | Buy → Buy | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.9% | -0.7% | -0.6% | -2.8% |
| Jan 23 | Citigroup | Maintains | Neutral → Neutral | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.9% | -0.7% | -0.6% | -2.8% |
| Jan 23 | Bernstein | Maintains | Outperform → Outperform | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.9% | -0.7% | -0.6% | -2.8% |
| Jan 9 | Bernstein | Maintains | Outperform → Outperform | — | $585.08 | $587.32 | +0.4% | +0.2% | -2.3% | -1.9% | -2.7% | -1.0% |
| Jan 7 | BTIG | Maintains | Buy → Buy | — | $592.85 | $592.89 | +0.0% | -0.1% | -1.2% | +0.2% | -2.3% | -1.9% |
| Jan 7 | Barclays | Maintains | Overweight → Overweight | — | $592.85 | $592.89 | +0.0% | -0.1% | -1.2% | +0.2% | -2.3% | -1.9% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $556.86 | $557.29 | +0.1% | +0.9% | +1.9% | +1.3% | -0.4% | -0.0% |
| Dec 17 | RBC Capital | Maintains | Outperform → Outperform | — | $554.58 | $554.68 | +0.0% | +0.4% | +0.9% | +1.9% | +1.3% | -0.4% |
| Dec 11 | Citigroup | Downgrade | Buy → Neutral | — | $555.92 | $545.47 | -1.9% | -1.5% | -0.9% | +3.2% | -0.9% | +0.4% |
| Oct 28 | Freedom Broker | Maintains | Buy → Buy | — | $551.25 | $546.62 | -0.8% | -1.1% | -1.4% | -1.4% | +0.8% | +1.9% |
| Oct 23 | UBS | Maintains | Neutral → Neutral | — | $527.03 | $525.37 | -0.3% | +4.6% | -0.9% | +0.9% | -1.1% | -1.4% |
| Oct 22 | BTIG | Maintains | Buy → Buy | — | $462.74 | $543.00 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% |
| Oct 22 | RBC Capital | Maintains | Outperform → Outperform | — | $462.74 | $543.00 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% |
| Oct 22 | Raymond James | Maintains | Outperform → Outperform | — | $462.74 | $543.00 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% |
| Oct 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $462.74 | $543.00 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% |
| Oct 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $462.74 | $543.00 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% |
| Oct 22 | Truist | Maintains | Buy → Buy | — | $462.74 | $543.00 | +17.3% | +13.9% | +4.6% | -0.9% | +0.9% | -1.1% |
| Oct 15 | Truist | Maintains | Buy → Buy | — | $436.39 | $437.00 | +0.1% | -0.2% | -0.2% | +2.6% | +2.8% | +0.9% |
| Oct 13 | BTIG | Maintains | Buy → Buy | — | $429.59 | $432.43 | +0.7% | +1.4% | +0.2% | -0.2% | -0.2% | +2.6% |
| Oct 7 | Evercore ISI | Maintains | In Line → In Line | — | $449.69 | $449.24 | -0.1% | -1.9% | +1.6% | -1.0% | -3.2% | +1.4% |
| Oct 1 | BTIG | Maintains | Buy → Buy | — | $447.23 | $447.00 | -0.1% | -2.1% | +1.1% | +2.1% | -0.6% | -1.9% |
| Aug 19 | RBC Capital | Maintains | Outperform → Outperform | — | $481.28 | $480.99 | -0.1% | -0.4% | +0.3% | -2.2% | +1.3% | -1.6% |
| Jul 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $511.00 | $522.50 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% |
| Jul 23 | RBC Capital | Maintains | Outperform → Outperform | — | $511.00 | $522.50 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% |
| Jul 23 | BTIG | Maintains | Buy → Buy | — | $511.00 | $522.50 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% |
| Jul 23 | UBS | Maintains | Neutral → Neutral | — | $511.00 | $522.50 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% |
| Jul 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $511.00 | $522.50 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% |
| Jul 23 | Truist | Maintains | Buy → Buy | — | $511.00 | $522.50 | +2.3% | -1.8% | -2.7% | +1.5% | -0.4% | +0.6% |
| Jul 8 | Evercore ISI | Maintains | In Line → In Line | — | $534.71 | $534.00 | -0.1% | -1.4% | +0.2% | -0.4% | -2.7% | +0.9% |
| Jun 9 | Deutsche Bank | Downgrade | Hold → Sell | — | $557.08 | $531.50 | -4.6% | -5.6% | +0.7% | -1.4% | -1.8% | -0.2% |
| May 22 | Citigroup | Maintains | Buy → Buy | — | $547.07 | $544.81 | -0.4% | -0.8% | -0.6% | +2.0% | +0.4% | +0.6% |
| Apr 24 | Barclays | Maintains | Overweight → Overweight | — | $487.93 | $490.82 | +0.6% | +4.1% | +1.3% | -0.1% | +0.2% | +0.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | LOEB GARYOff | EVP & Chief Legal and Complian | Sell | 400 | $424.14 | $170K | 5,720 | +0.21% | -3.57% |
| Jun 10, 2026 | Brosius MarkOff | EVP & Chief Mfg and Supply Cha | Sell | 23 | $424.14 | $10K | 1,454 | +0.21% | -3.57% |
| Jun 9, 2026 | Brosius MarkOff | EVP & Chief Mfg and Supply Cha | Sell | 23 | $421.13 | $10K | 1,477 | +0.21% | -3.57% |
| Jun 8, 2026 | Brosius MarkOff | EVP & Chief Mfg and Supply Cha | Sell | 23 | $420.12 | $10K | 1,500 | +0.21% | -3.57% |
| Jun 1, 2026 | Jeddi ImanOff | SVP & GM da Vinci Platforms & | Sell | 5,625 | $420.55 | $2.4M | 6,463 | +1.24% | +1.91% |
| May 20, 2026 | Brosius MarkOff | EVP & Chief Mfg and Supply Cha | Sell | 18 | $440.38 | $8K | 1,559 | -2.06% | +1.21% |
| May 19, 2026 | Brosius MarkOff | EVP & Chief Mfg and Supply Cha | Sell | 18 | $440.70 | $8K | 1,577 | -2.06% | +1.21% |
| May 18, 2026 | Brosius MarkOff | EVP & Chief Mfg and Supply Cha | Sell | 18 | $422.47 | $8K | 1,595 | -2.06% | +1.21% |
| May 11, 2026 | LOEB GARYOff | EVP & Chief Legal and Complian | Sell | 400 | $446.95 | $179K | 6,120 | +2.81% | +4.46% |
| Apr 29, 2026 | Ladd Amy LDir | — | Sell | 119 | $463.50 | $55K | 120 | +0.83% | +0.08% |
| Apr 28, 2026 | Ladd Amy LDir | — | Sell | 500 | $473.46 | $237K | 239 | +0.83% | +0.08% |
8-K
Intuitive Surgical Inc. -- 8-K Filing
Intuitive Surgical's Q1 2026 worldwide procedures grew 17% year-over-year across its da Vinci and Ion platforms, demonstrating strong demand for its robotic-assisted surgery systems.
Apr 21
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Accuray's appointment of an experienced Chief Commercial Officer signals management's confidence in accelerating sales growth and market expansion, which could drive revenue acceleration and improve investor sentiment if execution succeeds.
Apr 6
8-K · 8.01
!! High
Intel Corp -- 8-K 8.01: Material Event / Announcement
Intel's board will shrink to eleven directors after its 2026 annual meeting, reflecting organizational streamlining that may signal cost-reduction efforts amid the chipmaker's strategic transition.
Mar 3
8-K
Intuitive Surgical Inc. -- 8-K Filing
Intuitive Surgical (ISRG) completed its acquisition of da Vinci and Ion distribution operations in Southern Europe, directly expanding its surgical robotics market presence across Italy, Spain, Portugal, and Malta.
Mar 2
8-K · 1.01
!! High
UFP Technologies Inc -- 8-K 1.01: Supply Agreement
UFP Technologies secured an amended supply agreement with Intuitive Surgical, a key strategic customer, potentially strengthening revenue visibility and the long-term partnership in medical device manufacturing.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 23,079,490 | $10.6B | New | Mar 2026 |
| 2 | Morgan Stanley | 11,482,070 | $6.5B | Reduced | Dec 2025 |
| 3 | Capital World Investors | 8,048,010 | $3.7B | Added | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 7,233,971 | $3.3B | New | Mar 2026 |
| 5 | Fmr Llc | 5,477,234 | $2.5B | Reduced | Mar 2026 |
| 6 | Jpmorgan Chase & Co | 4,593,894 | $2.1B | Added | Mar 2026 |
| 7 | Jennison Associates Llc | 3,209,137 | $1.8B | Added | Dec 2025 |
| 8 | Invesco Ltd. | 3,737,430 | $1.7B | Reduced | Mar 2026 |
| 9 | Bank Of America Corp /de/ | 3,616,973 | $1.7B | Added | Mar 2026 |
| 10 | Bank Of New York Mellon Corp | 3,550,375 | $1.6B | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 3,504,272 | $1.6B | Reduced | Mar 2026 |
| 12 | Nuveen, Llc | 2,621,423 | $1.2B | Reduced | Mar 2026 |
| 13 | Amundi | 2,428,356 | $1.1B | New | Mar 2026 |
| 14 | Franklin Resources Inc | 2,339,439 | $1.1B | Reduced | Mar 2026 |
| 15 | Arrowstreet Capital, Limited Partnership | 2,105,544 | $971M | Added | Mar 2026 |
| 16 | Royal Bank Of Canada | 1,882,391 | $868M | Reduced | Mar 2026 |
| 17 | Assenagon Asset Management S.a. | 1,745,008 | $804M | Added | Mar 2026 |
| 18 | Janus Henderson Group Plc | 1,643,060 | $757M | New | Mar 2026 |
| 19 | Ubs Group Ag | 1,637,924 | $755M | Reduced | Mar 2026 |
| 20 | Barclays Plc | 1,592,310 | $734M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$147.54B
Enterprise Value
$141.74B
P/E (TTM)
51.69x
Forward P/E
39.32x
PEG Ratio
3.17x
P/B
8.09x
P/S
14.66x
P/FCF
59.24x
EV/EBITDA
39.13x
Shares Out
362.7M
Financials (TTM)
Revenue
$10.06B
Net Income
$2.86B
EBITDA
$3.62B
Free Cash Flow
$2.49B
Op Cash Flow
$3.03B
EPS Basic
$8.00
EPS Diluted
$7.87
EPS Forward
$10.34
Gross Margin
66.0%
Op Margin
29.3%
Net Margin
28.4%
Balance Sheet
Total Assets
$20.63B
Total Liab.
$2.69B
Total Equity
$17.94B
Cash
$5.93B
LT Debt
$131.9M
Book Value/Sh
$50.27
Debt/Equity
0.02x
Current Ratio
4.87
Quick Ratio
3.96
Returns & Growth
ROE
17.1%
ROA
14.8%
ROIC
13.7%
Rev Growth YoY
+20.5%
EPS Growth YoY
+22.3%
Price Returns
2W
-0.8%
1M
-7.2%
3M
-15.7%
6M
-26.0%
12M
-23.1%
Technicals
52W High
$592.85
52W Low
$402.18
50d MA
$439.73
200d MA
$490.69
RSI (14)
40.70
ATR (14)
$11.36
Beta
1.68
Avg Volume
2.5M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$622.60
High
$750.00
Low
$525.00
Median
$618.00
Data updated apr 25, 2026 4:21pm
· Source: financialmodelingprep.com